Scribe Therapeutics Inc. (SCTX)
NASDAQ: SCTX · Real-Time Price · USD
23.03
+1.26 (5.79%)
At close: Sep 29, 2026, 4:00 PM EDT
23.04
+0.01 (0.04%)
After-hours: Sep 29, 2026, 7:30 PM EDT
Scribe Therapeutics Market Cap
Scribe Therapeutics has a market cap or net worth of $436 million as of September 29, 2026.
Market Cap
436.00M
Enterprise Value
436.26M
1-Year Change
n/a
Ranking
Category
Stock Price
$23.03
ChartMarket Cap Chart
Since the IPO on July 24, 2026, Scribe Therapeutics's market cap has increased from $242.73M to $436.00M, an increase of 79.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 436.00M | 5.79% |
| Sep 28, 2026 | 412.14M | 2.30% |
| Sep 25, 2026 | 402.87M | -1.53% |
| Sep 24, 2026 | 409.11M | -18.55% |
| Sep 23, 2026 | 502.26M | -5.49% |
| Sep 22, 2026 | 531.41M | 0.07% |
| Sep 21, 2026 | 531.03M | -15.00% |
| Sep 18, 2026 | 624.75M | 2.68% |
| Sep 17, 2026 | 608.46M | 10.45% |
| Sep 16, 2026 | 550.91M | -8.09% |
| Sep 15, 2026 | 599.38M | 7.61% |
| Sep 14, 2026 | 556.97M | -1.08% |
| Sep 11, 2026 | 563.03M | 0.92% |
| Sep 10, 2026 | 557.92M | 0.20% |
| Sep 9, 2026 | 556.78M | -6.16% |
| Sep 8, 2026 | 593.32M | 9.31% |
| Sep 4, 2026 | 542.77M | -6.95% |
| Sep 3, 2026 | 583.29M | -0.29% |
| Sep 2, 2026 | 584.99M | 6.93% |
| Sep 1, 2026 | 547.07M | -5.04% |
| Aug 31, 2026 | 576.12M | 7.38% |
| Aug 28, 2026 | 536.50M | -1.39% |
| Aug 27, 2026 | 544.05M | -9.02% |
| Aug 26, 2026 | 598.00M | 1.59% |
| Aug 25, 2026 | 588.66M | -16.23% |
| Aug 24, 2026 | 702.70M | 9.14% |
| Aug 21, 2026 | 643.84M | 3.96% |
| Aug 20, 2026 | 619.32M | 5.73% |
| Aug 19, 2026 | 585.74M | 14.53% |
| Aug 18, 2026 | 511.41M | 27.94% |
| Aug 17, 2026 | 399.74M | 2.22% |
| Aug 14, 2026 | 391.06M | 1.77% |
| Aug 13, 2026 | 384.27M | -11.47% |
| Aug 12, 2026 | 434.07M | -1.83% |
| Aug 11, 2026 | 442.18M | -5.98% |
| Aug 10, 2026 | 470.29M | -4.12% |
| Aug 7, 2026 | 490.47M | 2.32% |
| Aug 6, 2026 | 479.34M | 6.76% |
| Aug 5, 2026 | 448.97M | 7.89% |
| Aug 4, 2026 | 416.15M | 5.88% |
| Aug 3, 2026 | 393.04M | 6.96% |
| Jul 31, 2026 | 367.48M | -4.51% |
| Jul 30, 2026 | 384.83M | 11.11% |
| Jul 29, 2026 | 346.35M | 1.66% |
| Jul 28, 2026 | 340.69M | -4.80% |
| Jul 27, 2026 | 357.86M | 47.43% |
| Jul 24, 2026 | 242.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Atea Pharmaceuticals | 414.66M |
| Rezolute | 409.10M |
| Relmada Therapeutics | 408.55M |
| YD Bio | 405.86M |
| ARS Pharmaceuticals | 405.75M |
| Prelude Therapeutics | 399.11M |
| Editas Medicine | 396.24M |
| Opus Genetics | 396.01M |